Tracks
Related Products
COMPARISON OF OUTCOMES FOR PATIENTS UNDERGOING SADI VS. RYGB IN 2020 AND 2021
BACKGROUND: Despite the advances in the multidisciplinary treatment of gastric adenocarcinoma, the overall 5-year survival remains only 33.3% in North America. R0 resection with adequate lymphadenectomy remains the mainstay therapy…
Panel II: Global Outreach Committee: International Advances in GI Surgery: Management of Esophageal Achalasia
SOCIETY: SSAT This panel will discuss new diagnostic methodologies and therapeutic techniques that have been added to the armamentarium for treating achalasia. Speakers will offer an up-to-date framework for making clinical decisions on the management of this disease…
ASSOCIATION BETWEEN BASELINE HEMOGLOBIN A1C AND 30-DAY OUTCOMES AFTER SLEEVE GASTRECTOMY AND ROUX-EN-Y GASTRIC BYPASS
Background: Metabolic and bariatric surgery (MBS) is a well-established treatment option in the management of obesity and its complications. At times, surgeons may delay MBS if the preoperative hemoglobin A1c (HbA1c) is elevated above a specified cutoff value…
Best of Stomach/Bariatric/Metabolic Diseases
SOCIETY: SSAT